✕
Login
Register
Back to News
Iovance Biotherapeutics Files Prospectus For Offering Mixed Shelf; Terms Undisclosed
Benzinga Newsdesk
www.benzinga.com
Neutral 93.2%
Neg 0%
Neu 93.2%
Pos 0%
https://www.sec.gov/Archives/edgar/data/1425205/000110465926075778/iova-20260618xs3asr.htm
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment